Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7339242

Concept 2023-10-01 to
2024-03-31
2022-10-01 to
2023-03-31
Statement of income
Statement of income
Net sales
21,388,000,000 JPY
19,225,000,000 JPY
Net sales
Operating revenue
Operating expenses
Cost of sales
Cost of sales
13,154,000,000 JPY
11,601,000,000 JPY
Selling, general and administrative expenses
6,789,000,000 JPY
5,799,000,000 JPY
Operating expenses
Research and development expenses
1,726,000,000 JPY
1,368,000,000 JPY
Operating profit (loss)
1,443,000,000 JPY
1,824,000,000 JPY
Gross profit (loss)
8,233,000,000 JPY
7,623,000,000 JPY
Ordinary profit (loss)
2,165,000,000 JPY
2,456,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
0 JPY
Gross profit
Non-operating expenses
Interest expenses
83,000,000 JPY
52,000,000 JPY
Non-operating income
Non-operating income
817,000,000 JPY
704,000,000 JPY
Financial revenue
Other
82,000,000 JPY
84,000,000 JPY
Extraordinary income
3,953,000,000 JPY
JPY
Selling, general and administrative expenses
Non-operating expenses
Non-operating expenses
Non-operating expenses
95,000,000 JPY
72,000,000 JPY
Financial expenses
Bond issuance costs
JPY
14,000,000 JPY
Other
9,000,000 JPY
5,000,000 JPY
Extraordinary losses
91,000,000 JPY
JPY
Extraordinary income
Gain on sale of investment securities
3,118,000,000 JPY
JPY
Profit (loss) before income taxes
6,027,000,000 JPY
2,456,000,000 JPY
Income taxes - current
1,432,000,000 JPY
367,000,000 JPY
Extraordinary losses
Loss on disaster
30,000,000 JPY
JPY
Income taxes - deferred
337,000,000 JPY
316,000,000 JPY
Income taxes
1,770,000,000 JPY
683,000,000 JPY
Profit (loss)
4,257,000,000 JPY
1,772,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.